Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib
Senem Maral1, Sule Mine Bakanay2, Aysun Senturk Yikilmaz2
1Department of Hematology, Ankara Ataturk Training and Research Hospital, Ankara, Turkey.
Abstract:
Plasma cell leukemia (PCL) is a rare and an aggressive form of plasma cell dyscrasias. We report a 67-year-old male with PCL which developed while on imatinib mesylate (IM) therapy 38 months after diagnosis of chronic myeloid leukemia (CML). The patient has been treated successfully with bortezomib, melphalan and prednisolone. To our knowledge, only one case of PCL superimposed on Philadelphia positive CML has been reported in the literature and this was before the IM era.
More Related Videos
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Composition of Blood Plasma
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Zygotic Development And Stem Cell Formation
Enlargement of the Plasma Membrane


